Synthetic Genomics and ExxonMobil renew algae research, but commercial adoption still decades away

ExxonMobil and Synthetic Genomics announced a fundamental scientific research agreement on algae to biofuels. While this announcement is a renewal of its partnership inked in 2009 (see the July 28, 2009 LRAFJ), it is a major change – from the original goal of commercialization within 10 years to ...

This item has been archived in line with our efforts to keep our content relevant and up to date for our readership. For further assistance, please contact your Customer Success Manager or email Thank you!

Related Research

IEA Bioenergy Task 39 report highlights roles of liquid-based fuels for decarbonizing aviation

News Commentary | July 09, 2021

The report "Progress in the Commercialization of Biojet / Sustainable Aviation Fuels" corroborates Lux's long stance that liquid‑based fuels will remain the dominant form of energy for the aviation sector. ICAO has also made a clear commitment to a similar roadmap through its 2050 ICAO Vision for ... Not part of subscription

Danimer Scientific throws Hail Mary to appease investors, acquiring Novomer for $152 million in cash

News Commentary | August 06, 2021

After going public via SPAC in December, Danimer Scientific has been under increased scrutiny, including a class‑action lawsuit for allegations that it overstated production figures, pricing, and financial projections for its core polyhydroxyalkanoate (PHA) technology – and looking for ways to re‑... Not part of subscription

Huh? CO₂-to-cellulose? Rubi Laboratories raises USD 4.5 million to develop CO₂-derived viscose

News Commentary | February 25, 2022

At the intersection of synthetic biology, CO2 utilization, and cellulosic fibers is Rubi Laboratories. Rubi is aiming to produce carbon‑negative viscose using its enzyme‑based CO2‑to‑cellulose technology. Unlike other CO2‑derived fiber developers like LanzaTech, Newlight Technologies, and Fairbrics ... Not part of subscription